IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model.
Sign Up to like & getrecommendations! Published in 2021 at "Cartilage"
DOI: 10.1177/19476035211026736
Abstract: OBJECTIVE Ideally, disease-modifying osteoarthritis (OA) drugs (DMOAD) should combine chondroprotective, anti-inflammatory, and analgesic effects in a single molecule. A fusion protein of interleukin-4 (IL-4) and IL-10 (IL4-10 FP) possesses these combined effects. In this study,… read more here.
Keywords: dmoad activity; activity rat; osteoarthritis; model ... See more keywords